J-F. Cordier (Lyon, France), P. Camus (Dijon, France), J. Jones (Viseu, Portugal), S. Tomassetti (Forli, Italy)
Interstitial lung diseases in children: The French national cohort study
N. Nathan, J. de Blic, R. Abou Taam, C. Delacourt, R. Epaud, A. Deschildre, P. Reix, R. Chiron, U. de Pontbriand, J. C. Dubus, L. Giovannini-Chami, F. Brémont, J. Brouard, C. Schweitzer, C. Marguet, M. L. Dalphin, V. Houdouin, F. Troussier, A. Sardet, E. Hullo, M. Fayon, I. Gibertini, K. Bessaci, M. Mahloul, D. Michon, J. F. Vibert, G. Thouvenin, B. Fauroux, H. Corvol, A. Clement, For the French RespiRare Group (Paris, Créteil, Lille, Lyon, Montpellier, Nantes, Marseille, Nice, Toulouse, Caen, Nancy, Rouen, Besançon, Angers, Lens, Grenoble, Bordeaux, Tours, Reims, France)
|  |
Diagnostic value of serum VEGF-D in consecutive patients with lymphangioleiomyomatosis
V. Cottin, J. Lacronique, L. Denis, P. Jaffray, C. Khouatra, R. Guelminger, D. Valeyre, H. Nunes, J. Bienvenu, B. Crestani, C. Taillé, J. F. Cordier (Lyon, Paris, Bobigny, France)
| |
Extracellular concentration and enzyme activity of proteasome in BAL of patients with alveolar proteinosis
F. Bonella, T. Anlasik, J. C. Thomassen, M. Cai, S. Ohshimo, J. Guzman, U. Costabel (Essen, Düsseldorf, Bochum, Germany; Hiroshima, Japan)
|  |
Chronic eosinophilic pneumonia after radiation therapy for breast cancer
M. Pons, A. Riglietti, I. Marsteller, V. Poletti, R. Lazor, A. Azzola (Lugano, Lausanne, Switzerland; Forli‘, Italy)
| |
Baseline characteristics of an Italian cohort of pulmonary alveolar proteinosis (PAP) patients
I. Campo, Z. Kadija, F. Mariani, G. Rodi, E. Paracchini, C. Chalk, B. C. Trapnell, M. Luisetti (Pavia, Italy; Cincinnati, United States Of America)
| |
Lymphocytes populations in bloods and lungs in patients with auto-immune pulmonary alveolar proteinosis
Y. Inoue, T. Arai, J. Otsuka, C. Sugimoto, M. Hirose, A. Natsumuro, Y. Iwaki, M. Nakagawa, S. Hayashi, M. Okada (Osaka, Japan)
| |
Old and novel surfactant protein C (SP-C) mutations in children
A. C. Grimmelt, M. Barker, F. Brasch, M. Gappa, M. Kappler, R. Kitz, C. Kroener, S. Lau, E. Lorenz, C. Pfannenstiel, M. Preosmans, J. Ripper, C. Werner, S. Zielen, M. Griese (Munich, Berlin, Bielefeld, Wesel, Frankfurt am Main, Frankfurt, Aachen, Leuven, Münster, Germany)
| |
Serum VEGF-D and VEGFR-3 are biomarkers in lymphangioleiomyomatosis for its diagnosis and impaired pulmonary function
H. Okabayashi, A. Masunaga, H. Ichiyasu, S. Tsumura, K. Kojima, K. Fujii, N. Saita, H. Kohrogi (Kumamoto, Japan)
| |
Lymphangioleiomyomatosis – Clinical characteristics and longitudinal follow-up of 36 cases
M. Sobiecka, J. Kus, S. Wesolowski, E. Radzikowska, M. Korzeniewska-Kosela (Warsaw, Poland)
| |
Relationships between respiratory impedance and prognosis in patients with end-stage pulmonary lymphangioleiomyomatosis: A concept based on the Helmholtz resonator
H. Hamakawa, H. Sakai, T. Bando, I. Matsumoto, T. Terashi, E. Miyamoto, R. Tachikawa, K. Tomii, Y. Takahashi, H. Date (Kobe, Kyoto, Japan)
| |
The efficiency of Langerhans‘ cell hystioctosis treatment (3 years follow-up)
O. Baranova, A. Speranskaja, I. Dvorakovskaya, E. Dembo-Smeathon, D. Dzadzua (Saint-Petersburg, Russian Federation)
| |
Pulmonary Langerhans-cell histiocytosis – Analysis of 57 cases
E. Radzikowska, E. Wiatr, A. Jarzemska, I. Bestry, R. Langfort, P. Rudzinski, K. Roszkowski-Sliz (Warsaw, Bydgoszcz, Poland)
| |
Long term follow-up in patients with pulmonary alveolar proteinosis
Y. Ilkovich, L. Novikova, O. Baranova, I. Dvorakovskaya, A. Bazhanov (St. Petersburg, Russian Federation)
| |
Lymphocytic interstitial pneumonia – Two cases of unusual presentation
J. Vale, E. Silva, V. Melo, J. Jones, R. Nunes, A. Simões Torres (Viseu, Portugal)
| |
Abnormalities between down regulation of cyclooxygenase-2 and up-regulation of grow factors in patients with systemic sclerosis
E. R. Parra, F. Lin, V. Capelozzi (São Paulo, Brazil)
| |
Features of pulmonary involvement in patients with diffuse connective tissue diseases
D. Petrova, Y. Shoikhet, S. Berestov, A. Dorokhov (Barnaul, Russian Federation)
| |
Arterial stiffness in systemic scleroderma patients with restrictive lung disease
N. Karoli, A. Rebrov (Saratov, Russian Federation)
| |
Lung function testing (LFT), diffusing capacity (DC) in patients with rheumatologic disorders: Is spirometry exclusionary?
G. Apti, H. Memis, A. Trailescu (Constanta, Bucharest, Romania)
| |
Features of pulmonary involvement in patients with diffuse connective tissue diseases depending on a nosological form
D. Petrova, Y. Shoikhet, A. Dorokhov, S. Berestov (Barnaul, Russian Federation)
| |
Pulmonary manifestations of systemic sclerosis, a report from Iran
A. Fakharian, N. Mansouri, M. Karimi, A. Zamani, D. Mansouri (Tehran, Islamic Republic Of Iran)
| |